Nabriva Therapeutics Statistics
Total Valuation
NBRVF has a market cap or net worth of $323. The enterprise value is -$1.71 million.
| Market Cap | 323 |
| Enterprise Value | -1.71M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
NBRVF has 3.23 million shares outstanding. The number of shares has increased by 27.72% in one year.
| Shares Outstanding | 3.23M |
| Shares Change (YoY) | +27.72% |
| Shares Change (QoQ) | +0.92% |
| Owned by Insiders (%) | 0.97% |
| Owned by Institutions (%) | 8.78% |
| Float | 3.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| Forward PS | 0.00 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.38
| Current Ratio | 0.38 |
| Quick Ratio | 0.26 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -112.44 |
Financial Efficiency
Return on equity (ROE) is -2,673.20%.
| Return on Equity (ROE) | -2,673.20% |
| Return on Assets (ROA) | -191.60% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $757,872 |
| Profits Per Employee | -$1.41M |
| Employee Count | 39 |
| Asset Turnover | 1.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NBRVF has paid $829,000 in taxes.
| Income Tax | 829,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.99% in the last 52 weeks. The beta is 1.64, so NBRVF's price volatility has been higher than the market average.
| Beta (1Y) | 1.64 |
| 52-Week Price Change | -99.99% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.32 |
| Relative Strength Index (RSI) | 36.32 |
| Average Volume (30 Days) | 2,693 |
Short Selling Information
The latest short interest is 44,595, so 1.38% of the outstanding shares have been sold short.
| Short Interest | 44,595 |
| Short Previous Month | 35,335 |
| Short % of Shares Out | 1.38% |
| Short % of Float | 1.47% |
| Short Ratio (days to cover) | 8.58 |
Income Statement
In the last 12 months, NBRVF had revenue of $29.56 million and -$55.05 million in losses. Loss per share was -$1.84.
| Revenue | 29.56M |
| Gross Profit | -4.72M |
| Operating Income | -54.03M |
| Pretax Income | -54.23M |
| Net Income | -55.05M |
| EBITDA | -53.65M |
| EBIT | -53.75M |
| Loss Per Share | -$1.84 |
Balance Sheet
The company has $2.26 million in cash and $540,000 in debt, giving a net cash position of $1.72 million or $0.53 per share.
| Cash & Cash Equivalents | 2.26M |
| Total Debt | 540,000 |
| Net Cash | 1.72M |
| Net Cash Per Share | $0.53 |
| Equity / Book Value | -16.32M |
| Book Value Per Share | -5.05 |
| Working Capital | -16.25M |
Cash Flow
In the last 12 months, operating cash flow was -$12.91 million and capital expenditures -$115,000, giving a free cash flow of -$13.02 million.
| Operating Cash Flow | -12.91M |
| Capital Expenditures | -115,000 |
| Free Cash Flow | -13.02M |
| FCF Per Share | -$0.40 |
Margins
Gross margin is -15.97%, with operating and profit margins of -182.81% and -186.26%.
| Gross Margin | -15.97% |
| Operating Margin | -182.81% |
| Pretax Margin | -183.46% |
| Profit Margin | -186.26% |
| EBITDA Margin | -181.50% |
| EBIT Margin | -181.84% |
| FCF Margin | -44.06% |
Dividends & Yields
NBRVF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.72% |
| Shareholder Yield | -27.72% |
| Earnings Yield | -17,044,582.04% |
| FCF Yield | -4,032,198.14% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on September 16, 2022. It was a reverse split with a ratio of 1:25.
| Last Split Date | Sep 16, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
NBRVF has an Altman Z-Score of -104.97 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -104.97 |
| Piotroski F-Score | 3 |